Can Exelixis Continue Making Big Moves?
Seeking Alpha
Important Cancer Therapeutics Under Development To Watch
Seeking Alpha
Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma
Yahoo/Business Wire
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Buy, Sell, or Hold: Exelixis
Motley Fool
Exelixis announces initiation of trial combining cabozantinib, abiraterone
Yahoo/Fly on the Wall
Exelixis Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients with Hepatocellular Carcinoma
Yahoo/BusinessWire
Exelixis 2011: Not What the Doctor Ordered
Motley Fool
Time decay is key to Exelixis strategy
Yahoo/optionMONSTER